7 Common Myths about Prostate Cancer

Prostate cancer has a PR problem: it’s common, often quiet, and surrounded by myths that refuse to leave the group chat.
Some myths are harmless (“your uncle’s friend’s neighbor swears by pumpkin seeds”), but others can delay screening,
create panic over a lab result, or push people into decisions they don’t actually need to make.

This article breaks down seven of the most common prostate cancer mythswhat’s actually true, why it matters, and what
questions are worth bringing to a real-life clinician (the kind with a stethoscope, not a Wi-Fi signal).

Quick reality check: what prostate cancer is (and isn’t)

The prostate is a small gland below the bladder that helps make semen. Prostate cancer happens when cells in the
prostate grow out of control. Some prostate cancers grow so slowly they may never cause problems. Others can be
aggressive and spreadmost commonly to bones or lymph nodes.

That “some slow, some fast” detail is exactly why myths are so dangerous: one-size-fits-all thinking doesn’t fit
prostate cancer at all.

Myth #1: “Only old men get prostate cancer.”

Reality: Risk rises with age, but it’s not an ‘old-only’ disease.

Age is a major risk factorprostate cancer becomes more common as men get older. But “more common” isn’t the same as
“exclusive.” Men in midlife can develop prostate cancer too, and the conversation about screening often starts well
before retirement age, especially for people at higher risk.

Why this myth matters

If someone thinks they’re “too young,” they may ignore early discussions about screening and risk factors. The goal
isn’t to panic earlyit’s to be appropriately aware early.

What to do instead

Know your personal risk: age, family history, genetics, and ancestry can shift the timeline for when screening
conversations should begin.

Myth #2: “If I don’t have symptoms, I don’t have prostate cancer.”

Reality: Early prostate cancer often has no symptoms.

One of prostate cancer’s least charming traits is that it can be symptom-free in early stages. Urinary changes,
pelvic discomfort, or bone pain are more likely with advanced diseasebut many men with treatable, localized prostate
cancer feel completely fine.

Why this myth matters

Waiting for symptoms can mean waiting until the disease is harder to treat. Also: urinary symptoms are common for
reasons that have nothing to do with cancer (like benign prostate enlargement). Symptoms are not a reliable sorting
hat.

What to do instead

If you’re in an age/risk group where screening is worth discussing, don’t let “I feel fine” end the conversation.
Feeling fine is great. Keep it that way.

Myth #3: “A high PSA level means I definitely have prostate cancer.”

Reality: PSA is a cluenot a verdict.

PSA (prostate-specific antigen) is a blood test that can help estimate risk. But PSA can rise for many reasons,
including benign prostate enlargement or inflammation. Some prostate cancers don’t produce much PSA, and some men
with elevated PSA don’t have cancer.

Why this myth matters

PSA anxiety is real. People see a number, assume the worst, and spiralsometimes straight into unnecessary tests,
sleepless nights, or rushed decisions. PSA is useful, but it’s not a standalone diagnosis.

What to do instead

Think “next step,” not “final answer.” A clinician may recommend repeating the PSA, looking at trends over time,
considering additional tests, imaging, or (when appropriate) biopsybased on the whole picture.

Myth #4: “Screening is always good, so everyone should get a PSA test every year.”

Reality: Screening is a personal decision because benefits and harms both exist.

PSA screening can help find cancers earlier, which may reduce deaths in certain groups. But screening can also lead
to false alarms, unnecessary biopsies, and overdiagnosisfinding slow-growing cancers that might never cause harm,
yet still trigger stress or treatment side effects.

That’s why many major health organizations emphasize shared decision-making for certain age ranges, rather than a
universal “everyone, every year” rule.

Why this myth matters

“Always screen” can ignore individual priorities and risk profiles. “Never screen” can also be harmfulespecially
for higher-risk individuals. The smart move is informed screening, not automatic screening.

What to do instead

Have a real conversation about your age, family history, ancestry, and health status. Ask what screening schedule,
if any, fits your risk and your values (for example, how you weigh early detection against the possibility of
unnecessary follow-up).

Myth #5: “The digital rectal exam is the main way to screen for prostate cancer.”

Reality: PSA blood testing is central to modern screening discussions; the rectal exam is not the whole story.

The digital rectal exam (DRE) has been part of prostate evaluation for a long time, but it has limitationsespecially
as a solo screening tool. Many screening approaches rely primarily on PSA testing, sometimes paired with other tools
when needed.

Why this myth matters

Some people avoid screening because they think a DRE is the unavoidable main event. Others assume a normal DRE means
“no cancer,” which isn’t a safe assumption either.

What to do instead

If screening is on the table, ask what the process looks like today. In many cases, it starts with a blood test and
a discussionsimple, quick, and far less dramatic than the myths suggest.

Myth #6: “Treatment always causes impotence or incontinence.”

Reality: Side effects are possible, but not guaranteedand treatment isn’t always immediate.

Let’s be honest: treatment side effects are a big fear, and it’s not irrational. Surgery, radiation, and hormone
therapy can affect sexual function, urinary control, or bowel habits. But “always” is the myth. Side effects vary
based on treatment type, cancer characteristics, surgical technique, radiation approach, baseline health, and time.

Also, not everyone needs immediate treatment. For many low-risk, slow-growing cancers, active surveillance is a
widely used approach: careful monitoring with the option to treat if the cancer shows signs of progression. That
means some men avoid or delay treatment-related side effects for years.

Why this myth matters

Fear can lead to two bad outcomes: avoiding evaluation entirely (“I’d rather not know”), or rushing into aggressive
treatment even when a conservative approach is appropriate.

What to do instead

Ask about your cancer’s risk category and the full menu of options: active surveillance, surgery, radiation, hormone
therapy, and newer or more targeted strategies in certain cases. Then talk honestly about what side effects you care
about most and what support exists to manage them.

Myth #7: “Prostate cancer is always deadly (or always slow), so it’s either terrifying or nothing.”

Reality: Prostate cancer has a wide range of behavior.

Two opposite myths share the same flaw: oversimplification. Some prostate cancers are indolent and may never become
life-threatening. Others are aggressive and can spread. The key is risk stratificationfiguring out which kind you’re
dealing with using PSA, imaging, biopsy results, grade group/Gleason scoring, staging, and overall health context.

Why this myth matters

If someone assumes “it’s always deadly,” they may panic and push for the most extreme option immediately. If they
assume “it’s always slow,” they may ignore a higher-risk cancer that needs treatment now.

What to do instead

Focus on specifics: What’s the stage? What’s the grade group? Has it spread? What’s the estimated risk of growth or
recurrence? Good decisions come from details, not from vibes.

Putting it all together: smarter questions (that beat myths every time)

If prostate cancer is part of your lifethrough your own health, a family member, or just future planningthese
questions cut through most misinformation:

• Based on my age and risk factors, should I discuss PSA screening now?
• If my PSA is elevated, what non-cancer causes are possible, and what’s the next step?
• If cancer is found, what risk category is itand is active surveillance appropriate?
• What are the realistic side effects of each treatment option for someone like me?
• How will we monitor over time (PSA trend, imaging, repeat biopsy when needed)?

Conclusion

Prostate cancer myths tend to be loud, confident, and wronglike that one relative who “did their research” on a
message board at 2 a.m. The truth is more nuanced: early prostate cancer can be silent, PSA is helpful but imperfect,
screening is a shared decision, and treatment is not one-size-fits-all. Many men do very wellespecially when they
replace fear and misinformation with informed conversations and individualized care.

If you remember only one thing, make it this: don’t let a myth make your health decisions for you.

Experiences That Feel Familiar: What People Commonly Report (and What It Teaches Us)

The internet is full of “I heard…” stories about prostate cancer. Some are helpful, some are misleading, and many are
missing context. Below are common experiences patients and families often describeshared here in a general,
educational wayto show how myths collide with real life.

1) “My PSA went up and I immediately assumed the worst.”

A lot of men describe the PSA test as emotionally weird: you feel fine, you get a blood draw, and suddenly a single
number seems to be narrating your future. Many people report a burst of anxietyGoogling in the parking lot, replaying
every health decision they’ve ever made, and deciding they should have eaten more broccoli in 2009.

The lesson: a PSA result is not a diagnosis. People who felt calmer later often say the turning point was learning
that PSA can rise for multiple reasons, that trends matter, and that clinicians often repeat tests or use additional
tools to clarify risk. In other words, the most helpful “treatment” for PSA panic is usually information and a plan.

2) “I had no symptoms… which made the diagnosis extra shocking.”

This is probably the most common plot twist. Many men who are diagnosed with early-stage prostate cancer say they
felt completely normal. Some even feel guilty, like they “missed” signs they were supposed to notice. Others feel
angry because they assumed cancer always announces itself with dramatic symptoms and a scary soundtrack.

The lesson: symptom-free doesn’t equal problem-free. Men who reflect positively on their experience often credit one
thing: they had a clinician who explained the difference between early silent disease and later symptoms, and they
learned that screening can find issues before the body starts waving red flags.

3) “I thought treatment would automatically ruin my quality of life.”

Fear of sexual side effects and urinary leakage is realand it’s one reason some men delay evaluation or avoid
follow-up. But many men describe a more nuanced reality once they talk with specialists: side effects vary, there
are ways to reduce risk, and there is support for recovery and symptom management.

Another common surprise is learning that “treatment” isn’t always the first move. Men placed on active surveillance
often describe relief: they’re not ignoring cancer, but they’re also not rushing into treatments they may not need
yet. Many say the experience felt like switching from a horror movie to a documentarystill serious, but finally
understandable.

4) “The best part was having a decision framework.”

Patients often report that the most stressful phase is the in-between period: after a concerning test, before a
clear plan. What helps is a framework that organizes the chaos: risk category, staging, likely growth pattern,
options, and tradeoffs. People describe feeling empowered when clinicians explain what the numbers mean, what is
urgent versus what can be monitored, and how personal priorities (like preserving sexual function, avoiding certain
side effects, or minimizing procedures) fit into the decision.

The lesson: prostate cancer care is rarely about one “right” choice for everyone. It’s about the right choice for
one personusing evidence, not myths.

5) “I wish we talked about family history earlier.”

Families often look back and realize no one connected the dots between prostate cancer and other cancers in the
family, or they didn’t realize genetics can influence risk. Many people report that once they shared a detailed
family historyespecially patterns like prostate, breast, or ovarian cancerscreening and risk conversations became
more targeted and more useful.

The lesson: your family history is not small talk. It’s clinical information. Bring it to appointments, and update
it when new diagnoses happen in relatives.

If you’re reading this because you’re worried, you’re not aloneand you’re not overreacting. Just make sure the next
step is a conversation based on real facts, not a myth that happens to be catchy.